Diabetes Mellitus, Smoking Status, and Rate of Sputum Culture Conversion in Patients with Multidrug-Resistant Tuberculosis: A Cohort Study from the Country of Georgia

被引:34
作者
Magee, Matthew J. [1 ,2 ]
Kempker, Russell R. [3 ]
Kipiani, Maia [4 ]
Tukvadze, Nestani [4 ]
Howards, Penelope P. [1 ]
Narayan, K. M. Venkat [1 ,2 ]
Blumberg, Henry M. [1 ,2 ,3 ]
机构
[1] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
[4] Natl Ctr TB & Lung Dis, Tbilisi, Georgia
来源
PLOS ONE | 2014年 / 9卷 / 04期
关键词
TREATMENT OUTCOMES; PREDICTORS; ASSOCIATION; IMPACT; RISK;
D O I
10.1371/journal.pone.0094890
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction: Diabetes mellitus (DM) is a risk factor for active tuberculosis (TB) but little is known about the effect of DM on culture conversion among patients with multidrug-resistant (MDR)-TB. The primary aim was to estimate the association between DM and rate of TB sputum culture conversion. A secondary objective was to estimate the association between DM and the risk of poor treatment outcomes among patients with MDR-TB. Materials and Methods: A cohort of all adult patients starting MDR-TB treatment in the country of Georgia between 20092011 was followed during second-line TB therapy. Cox proportional models were used to estimate the adjusted hazard rate of sputum culture conversion. Log-binomial regression models were used to estimate the cumulative risk of poor TB treatment outcome. Results: Among 1,366 patients with sputum culture conversion information, 966 (70.7%) had culture conversion and the median time to conversion was 68 days (interquartile range 50-120). The rate of conversion was similar among patients with MDR-TB and DM (adjusted hazard ratio [aHR] 0.95, 95% CI 0.71-1.28) compared to patients with MDR-TB only. The rate of culture conversion was significantly less in patients that currently smoked (aHR 0.82, 95% CI 0.71-0.95), had low body mass index (aHR 0.71, 95% CI 0.59-0.84), second-line resistance (aHR 0.56, 95% CI 0.43-0.73), lung cavities (aHR 0.70, 95% CI 0.59-0.83) and with disseminated TB (aHR 0.75, 95% CI 0.62-0.90). The cumulative risk of poor treatment outcome was also similar among TB patients with and without DM (adjusted risk ratio [aRR] 1.03, 95% CI 0.93-1.14). Conclusions: In adjusted analyses, DM did not impact culture conversion rates in a clinically meaningful way but smoking did.
引用
收藏
页数:9
相关论文
共 35 条
  • [1] [Anonymous], GLOB TUB REP 2013
  • [2] [Anonymous], 2013, Diabetes Atlas, V6th edn
  • [3] Aragon J., 2003, Phil J Internal Medicine, V41, P7
  • [4] The impact of diabetes on tuberculosis treatment outcomes: A systematic review
    Baker, Meghan A.
    Harries, Anthony D.
    Jeon, Christie Y.
    Hart, Jessica E.
    Kapur, Anil
    Loennroth, Knut
    Ottmani, Salah-Eddine
    Goonesekera, Sunali D.
    Murray, Megan B.
    [J]. BMC MEDICINE, 2011, 9
  • [5] Chiang CY., 2013, Respirology
  • [6] Tuberculosis and diabetes mellitus: convergence of two epidemics
    Dooley, Kelly E.
    Chaisson, Richard E.
    [J]. LANCET INFECTIOUS DISEASES, 2009, 9 (12) : 737 - 746
  • [7] Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes
    Eugenia Jimenez-Corona, Maria
    Pablo Cruz-Hervert, Luis
    Garcia-Garcia, Lourdes
    Ferreyra-Reyes, Leticia
    Delgado-Sanchez, Guadalupe
    Bobadilla-del-Valle, Miriam
    Canizales-Quintero, Sergio
    Ferreira-Guerrero, Elizabeth
    Baez-Saldana, Renata
    Tellez-Vazquez, Norma
    Montero-Campos, Rogelio
    Mongua-Rodriguez, Norma
    Areli Martinez-Gamboa, Rosa
    Sifuentes-Osornio, Jose
    Ponce-de-Leon, Alfredo
    [J]. THORAX, 2013, 68 (03) : 214 - 220
  • [8] Type 2 diabetes and multidrug-resistant tuberculosis
    Fisher-Hoch, Susan P.
    Whitney, Erin
    Mccormick, Joseph B.
    Crespo, Gonzalo
    Smith, Brian
    Rahbar, Mohammad H.
    Restrepo, Blanca I.
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (11-12) : 888 - 893
  • [9] A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
    Fitzpatrick, Christopher
    Floyd, Katherine
    [J]. PHARMACOECONOMICS, 2012, 30 (01) : 63 - 80
  • [10] Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
    Gandhi, Neel R.
    Nunn, Paul
    Dheda, Keertan
    Schaaf, H. Simon
    Zignol, Matteo
    van Soolingen, Dick
    Jensen, Paul
    Bayona, Jaime
    [J]. LANCET, 2010, 375 (9728) : 1830 - 1843